N/A

Award Information
Agency:
National Science Foundation
Branch:
N/A
Amount:
$100,000.00
Award Year:
2001
Program:
SBIR
Phase:
Phase I
Contract:
0109733
Agency Tracking Number:
0109733
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Orbital Research, Inc.
673 G Alpha Drive, Cleveland, OH, 44143
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 Frederick Lisy
 (440) 449-5785
 lisy@orbitalresearch.com
Business Contact
 Frederick Lisy
Title: Vice President
Phone: (440) 449-5785
Email: Lisy@orbitalresearch.com
Research Institution
N/A
Abstract
This Small Business Innovative Research (SBIR) Phase I project will develop a novel and flexible, dry, physiological recording electrode that conforms to non-planar surfaces and does not require extensive surface preparation or conductive gels to achieve a low impedance interface with the body. This innovative electrode will be fabricated inexpensively using microfabrication techniques and priced competitively with existing commercial electrodes despite its enhanced performance and features. The proposed dry electrode will provide substantial improvement in all areas of biomedical research and medicine that involve use of electro- physiological potentials such as EEG, EMG, EOG, and ECG signals. This unique electrode is particularly well suited for long-term and multiple electrode physiological monitoring as compared to existing commercial electrodes,since multiple electrodes can be easily fabricated into a single array with a common connector, thereby simplifying application. Additionally, by providing a low impedance interface with the body, this electrode will eliminate the need for an electrolytic gel or the need to abrade the skin prior to applying the electrode. The commercial applications of this project will follow directly from the development of the novel electrode (Orbital Research Dry Physiological Recording Electrode) that seeks to improve electro-physiological signal quality (for EEGs, EMGs, ECGs or EOGs), eliminates the harsh side effects and signal deterioration common with existing electrodes and is competitively priced. By enhancing quality of life at no additional cost, this biomedical innovation is expected to lead to new long-term monitoring applications.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government